Incidence of squamous cell carcinoma in patients with lung cancer diagnosed by computed tomography and pathohistologically in 2022 at CHC Rijeka
DOI:
https://doi.org/10.55378/rv.47.2.7Keywords:
CT, lung tumours, smoking tobacco, squamous cell carcinomaAbstract
Aim: The aim of this research was to determine the histological types of lung cancer among patients diagnosed with primary lung cancer by CT and pathohistologically, and to determine the prevalence of squamous cell carcinoma. Furthermore, to determine gender and age distribution and the proportion of smokers and non-smokers among respondents with diagnosed squamous cell carcinoma in relation to patients with adenocarcinoma.
Methods: This retrospective study included patients in whom the lung cancer was diagnosed in 2022 at the Clinical Hospital Center (CHC) Rijeka. All data necessary for the conduct of this study (age and gender, pathohistological findings, the diagnostic method by which the material for pathohistological analysis was obtained and smoking status) were obtained from hospital databases (IBIS and ISSA).
Results: A total of 147 diagnosed primary lung cancers were detected in this study. Lung cancer showed a male predominance with 65,3% while the proportion of female patients was 34,7%. The most common histological type of lung cancer was adenocarcinoma, confirmed in 40,8% of patients, followed by squamous cell carcinoma, which was diagnosed in 22,4% of patients. The male gender was more prevalent in patients with adenocarcinoma and squamous cell carcinoma, with the incidence of 63,3% and 75,5%. Analysis of the smoking status showed that 80% of patients with adenocarcinoma and 94% of patients with squamous cell carcinoma were smokers. The incidence of smokers among men diagnosed with adenocarcinoma and squamous cell carcinoma was approximately equal (92.2% vs. 92%). The proportion of smokers among women with adenocarcinoma was 59.1% while all women with squamous cell carcinoma were smokers.
Conclusion: Squamous cell carcinoma was the second most common histological type in patients diagnosed with lung cancer in 2022 at CHC Rijeka, after adenocarcinoma, with the incidence of 22.4%. Squamous cell carcinoma showed a significantly higher incidence in male patients (75,8% vs. 24,2%). Furthermore, the proportion of smokers was higher among the patients diagnosed with squamous cell carcinoma compared to those diagnosed with adenocarcinoma (94% versus 80%).
References
Global cancer observatory [Internet]. Ženeva: World Health Organization IARC; 2022 https://www.who.int/news-room/fact-sheets/detail/cancer
Ministrastvo zdravstva Republike Hrvatske. Nacionalni program za probir i rano otkrivanja raka pluća 2020-2024. Zagreb: Ministrastvo zdravstva Republike Hrvatske; 2020.
Miše K, Bradarić A, Sviličić A, Vučković M, Kotarac S, Tomić S, Janković S. Epidemiological Analysis of Lung Carcinoma in the Central Dalmatia Region: Results of Twenty-Year Follow-Up. Acta clinica Croatica. 2002;41(1):87-92.
Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med. 2011 Dec;32(4):605-44.
Marasović Šušnjar I, Vejić M. Prevalence of smoking in Croatia – How to solve the problem. Acta Med Croatica. 2020;74(2):189–195.
Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A. Epidemiology of lung cancer. Contemp Oncol (Pozn). 2021;25(1):45-52.
Pikor LA, Ramnarine VR, Lam S, Lam WL. Genetic alterations defining NSCLC subtypes and their therapeutic implications. Lung Cancer. 2013 Nov;82(2):179-89.
Jukica L, Senovski B, Šimundža I, Mladinov S, Čapkun V, Glavina Durdov M. Analysis of overal survival in patients with lung cancer before the introduction of tyrosine kinase inhibitors and immunotherapy in the Republic of Croatia – a single institution study. Acta medica Croatica. 2021;75(4):273-280.
Zhou C. Lung cancer molecular epidemiology in China: recent trends. Transl Lung Cancer Res. 2014 Oct;3(5):270-9.
Darling HS, Viswanath S, Singh R, Ranjan S, Pathi N, Rathore A, Pathak A, Sud R. A clinico-epidemiological, pathological, and molecular study of lung cancer in Northwestern India. J Cancer Res Ther. 2020 Jul-Sep;16(4):771-779.
Mangone L, Marinelli F, Bisceglia I, Zambelli A, Zanelli F, Pagano M, Alberti G, Morabito F, Pinto C. Changes in the Histology of Lung Cancer in Northern Italy: Impact on Incidence and Mortality. Cancers (Basel). 2023 Jun 14;15(12):3187.
Fan H, Shao ZY, Xiao YY, Xie ZH, Chen W, Xie H, Qin GY, Zhao NQ. Incidence and survival of non-small cell lung cancer in Shanghai: a population-based cohort study. BMJ Open. 2015 Dec 23;5(12):e009419.
Lahmadi M, Beddar L, Ketit S, Filali T, Djemaa A, Satta D. Epidemiological and clinicopathological features of lung cancer in Algeria. Research Square; 2022
Barta JA, Powell CA, Wisnivesky JP. Global Epidemiology of Lung Cancer. Ann Glob Health. 2019 Jan 22;85(1):8.
Sagerup CM, Smastuen M, Johannesen TB, Helland Å, Brustugun OT. Sex-specific trends in lung cancer incidence and survival: a population study of 40,118 cases. Thorax. 2011 Apr;66(4):301-7.
Cancer Stat Facts: Lung and Bronchus Cancer [Internet]. Bethesda. National cancer institute. U.S. Department of Health and Human Service. 2022.
Darling HS, Viswanath S, Singh R, Ranjan S, Pathi N, Rathore A, Pathak A, Sud R. A clinico-epidemiological, pathological, and molecular study of lung cancer in Northwestern India. J Cancer Res Ther. 2020 Jul-Sep;16(4):771-779.
Mohammad A. ALQudah, Mahmoud A. ALFaqih, Shadi Hamouri et al. Epidemiology and histopathological classification of lung cancer: A study from Jordan, retrospective observational study. Ann Med Surg (Lond). 2021 May; 65: 102330.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2023 Elizabeta Daus, Ena Mršić, Melita Kukuljan (Autor)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
CART